CovarsaDx Welcomes Dr. Karen Shannon to Strengthen Legal Compliance and Innovation Efforts CovarsaDx adds Dr. Karen L. Shannon as in-house counsel, enhancing its commitment to compliance and paving the way for innovative advancements in clinical research.

CovarsaDx Welcomes Dr. Karen Shannon to Strengthen Legal Compliance and Innovation Efforts #USA #Las_Vegas #CovarsaDx #Legal_Compliance #Dr._Karen_Shannon

CovarsaDx Welcomes David Ikeda to Enhance Regulatory Strength in Clinical Research CovarsaDx proudly announces the addition of David Ikeda, a regulatory affairs expert, bolstering its capabilities in navigating global markets for IVDs.

CovarsaDx Welcomes David Ikeda to Enhance Regulatory Strength in Clinical Research #United_States #Los_Angeles #CovarsaDx #Regulatory_Affairs #David_Ikeda

CovarsaDx Achieves FDA Approval for Innovative COVID-19/Flu Antigen Tests Offered by OSANG Healthcare The FDA has granted CovarsaDx and OSANG Healthcare clearance for the QuickFinder™ COVID-19/Flu antigen tests, enhancing at-home diagnostics.

CovarsaDx Achieves FDA Approval for Innovative COVID-19/Flu Antigen Tests Offered by OSANG Healthcare #USA #Los_Angeles #CovarsaDx #OSANG_Healthcare #QuickFinder

Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis Nuclein's DASH® SARS-CoV-2 & Flu A/B Test has obtained FDA 510(k) clearance and CLIA waiver, revolutionizing rapid diagnostic testing.

Nuclein's DASH® SARS-CoV-2 & Flu A/B Test Achieves FDA Clearance for Rapid Diagnosis #USA #Austin #Nuclein #CovarsaDx #DASH_Test